Plus Therapeutics, Inc. (PSTV) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 39.87M |
| Enterprise Value | 31.93M |
| P/E Ratio | -0.01 |
| PEG Ratio | -0 |
| Price/Sales Ratio | 1.81 |
| Price/Book Ratio | 2.15 |
| Enterprise/Revenue | 1.36 |
| Enterprise/EBITDA | -0.86 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | -2.3 |
| Operating Margin | -3.64 |
AD
Management Effectiveness
| Return On Assets | -0.6 |
| Return On Equity | -1.98 |
Income Statement
| Revenue | 5.21M |
| Revenue/Share | 0.78 |
| Gross Profit | 4.77M |
| EBITDA | -18.33M |
| Net Income | -22.39M |
| Diluted EPS | -7.19 |
Balance Sheet
| Total Cash | 3.02M |
| Total Cash/Share | 0.45 |
| Total Debt | 725,000 |
| Total Debt/Equity | 0.06 |
| Current Ratio | 2.27 |
| Book Value Per Share | 1.8 |
Price History
| 52-Week Change | -73.55 |
| 52-Week High | 23.5 |
| 52-Week Low | 2.9 |
| Moving Average 50 Days | 4.66 |
| Moving Average 200 Days | 8.43 |
Statistics
| Average Volume | 161,925 |
| Shares Outstanding | 2.42M |
| % Held by Institutions | 5.5 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:25 |
| Last Split Date | April 02, 2026 |
AD
